Cornerstone Planning Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$836 Hold
100
﹤0.01% 1165
2025
Q1
$796 Hold
100
﹤0.01% 1181
2024
Q4
$801 Hold
100
﹤0.01% 1012
2024
Q3
$812 Buy
+100
New +$812 ﹤0.01% 985